Cboe Global Markets (CBOE) Product Launch summary
Event summary combining transcript, slides, and related documents.
Product Launch summary
3 Feb, 2026Product launch details
S&P 500 variance futures will begin trading on September 23, 2024, pending regulatory review, offering cash-settled exposure to realized variance of the S&P 500 in variance units, with contracts spanning from one month to over a year in duration.
The contract is designed for immediate clearing and operational simplicity, addressing issues from previous iterations and making it accessible to a broader range of participants, including retail and institutional investors.
Contracts settle on annualized realized variance of the S&P 500 Index, aligning expiration with standard SPX options for flexibility, and have a contract size set at $12, quoting and trading directly in variance units.
A variance calculator will be available to help users convert between futures price, implied volatility, vega notional, and contract size, enhancing usability and transparency.
The product offers an exchange-listed alternative to OTC variance swaps, simplifying variance trading and settlement.
Market context and user benefits
The listed product addresses challenges in the OTC variance swap market, such as counterparty risk, valuation discrepancies, and limited access, by providing transparency, liquidity, and broader participation.
The new futures are expected to attract a wide range of users, from hedge funds and asset managers to pension funds and insurance companies, with initial demand likely from existing OTC participants seeking lower margin and collateral requirements.
The product is positioned as a missing link in the S&P volatility complex, enabling more direct and flexible trading of realized volatility and supporting the development of related products.
Designed to be more accessible, capital-efficient, and user-friendly, reducing operational complexities of OTC swaps.
Launch timing leverages increased costs of OTC derivatives due to Uncleared Margin Rules and evolving regulatory landscape.
Evolution and future potential
If successful, the product could expand to include more contract expirations, options on variance futures, and similar contracts on other indices like the Russell 2000.
The design allows for potential granularity, such as trading forward variance or event-specific risk, similar to the evolution of VIX products.
Latest events from Cboe Global Markets
- Q2 2026 net revenue up 25% and diluted EPS up 50%, with raised 2026 growth targets.CBOE
Q2 2026 - Record financial growth, strategic focus, and all board proposals passed except written consent.CBOE
AGM 2026 - Record Q1 2026 revenue and EPS growth, with major realignment and raised growth guidance.CBOE
Q1 2026 - Board recommends all management proposals, highlights record performance, and opposes written consent rights.CBOE
Proxy filing - Record revenue and margin growth in 2025, with strong outlook and focus on core innovation.CBOE
47th Annual Raymond James Institutional Investor Conference - Record Q4 and full-year growth in revenue and EPS, with robust 2026 outlook and strategic focus.CBOE
Q4 2025 - Focus shifts to core growth, retail innovation, and global expansion amid strong market trends.CBOE
Barclays 23rd Annual Global Financial Services Conference - Record Q2 revenue and adjusted EPS growth, offset by a digital asset impairment.CBOE
Q2 2024 - Record index option volumes and global expansion drive growth, with disciplined capital allocation.CBOE
Piper Sandler Global Exchange and Trading Conference 2024